お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は女性の健康市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは女性の健康の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の女性の健康市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは女性の健康のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に女性の健康市場を分類しています。本研究に含まれる主な企業は：Veru Inc.、Allergan、Bayer AG、Merck、Pfizer、Teva Pharmaceuticals、Agile Therapeutics、Amgen, Inc.、AstraZeneca、Bristol-Myers Squibb

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Medicines
    Treatment
    Other

用途別の市場セグメント：
    Postmenopausal Osteoporosis
    Infertility
    Endometriosis
    PCOS
    Other

本レポートの詳細内容
世界の女性の健康市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、女性の健康タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の女性の健康収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の女性の健康市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、女性の健康市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

女性の健康のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：女性の健康のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：女性の健康の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章女性の健康企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：女性の健康の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：女性の健康の主要企業の概要を提供し、製品の説明と仕様、女性の健康の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Market Analysis and Insights: Global Female Health Market
The global Female Health market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Female Health is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Female Health is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Female Health is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Female Health include Veru Inc., Allergan, Bayer AG, Merck, Pfizer, Teva Pharmaceuticals, Agile Therapeutics, Amgen, Inc. and AstraZeneca, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Female Health is widely used in various fields, such as Postmenopausal Osteoporosis, Infertility, Endometriosis and PCOS, etc. Postmenopausal Osteoporosis provides greatest supports to the Female Health industry development. In 2023, global % revenue of Female Health went into Postmenopausal Osteoporosis filed and the proportion will reach to % in 2030. 
Report Covers:
This report presents an overview of global market for Female Health market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Female Health, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Female Health, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Female Health revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Female Health market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Female Health revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
    Veru Inc.
    Allergan
    Bayer AG
    Merck
    Pfizer
    Teva Pharmaceuticals
    Agile Therapeutics
    Amgen, Inc.
    AstraZeneca
    Bristol-Myers Squibb

Segment by Type
    Medicines
    Treatment
    Other

Segment by Application
    Postmenopausal Osteoporosis
    Infertility
    Endometriosis
    PCOS
    Other

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Female Health in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Female Health companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Female Health revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Female Health Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Medicines
    Table 3. Key Players of Treatment
    Table 4. Key Players of Other
    Table 5. Global Female Health Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Female Health Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Female Health Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Female Health Market Share by Region (2019-2024)
    Table 9. Global Female Health Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Female Health Market Share by Region (2025-2030)
    Table 11. Female Health Market Trends
    Table 12. Female Health Market Drivers
    Table 13. Female Health Market Challenges
    Table 14. Female Health Market Restraints
    Table 15. Global Female Health Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Female Health Revenue Share by Players (2019-2024)
    Table 17. Global Top Female Health by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Female Health as of 2023)
    Table 18. Global Female Health Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Female Health Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Female Health, Headquarters and Area Served
    Table 21. Global Key Players of Female Health, Product and Application
    Table 22. Global Key Players of Female Health, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Female Health Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Female Health Revenue Market Share by Type (2019-2024)
    Table 26. Global Female Health Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Female Health Revenue Market Share by Type (2025-2030)
    Table 28. Global Female Health Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Female Health Revenue Share by Application (2019-2024)
    Table 30. Global Female Health Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Female Health Revenue Share by Application (2025-2030)
    Table 32. North America Female Health Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Female Health Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Female Health Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Female Health Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Female Health Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Female Health Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Female Health Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Female Health Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Female Health Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Female Health Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Female Health Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Female Health Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Female Health Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Female Health Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Female Health Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Female Health Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Female Health Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Female Health Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Female Health Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Female Health Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Female Health Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Female Health Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Female Health Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Female Health Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Female Health Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Female Health Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Female Health Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Female Health Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Female Health Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Female Health Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Female Health Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Female Health Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Veru Inc. Company Details
    Table 65. Veru Inc. Business Overview
    Table 66. Veru Inc. Female Health Product
    Table 67. Veru Inc. Revenue in Female Health Business (2019-2024) & (US$ Million)
    Table 68. Veru Inc. Recent Developments
    Table 69. Allergan Company Details
    Table 70. Allergan Business Overview
    Table 71. Allergan Female Health Product
    Table 72. Allergan Revenue in Female Health Business (2019-2024) & (US$ Million)
    Table 73. Allergan Recent Developments
    Table 74. Bayer AG Company Details
    Table 75. Bayer AG Business Overview
    Table 76. Bayer AG Female Health Product
    Table 77. Bayer AG Revenue in Female Health Business (2019-2024) & (US$ Million)
    Table 78. Bayer AG Recent Developments
    Table 79. Merck Company Details
    Table 80. Merck Business Overview
    Table 81. Merck Female Health Product
    Table 82. Merck Revenue in Female Health Business (2019-2024) & (US$ Million)
    Table 83. Merck Recent Developments
    Table 84. Pfizer Company Details
    Table 85. Pfizer Business Overview
    Table 86. Pfizer Female Health Product
    Table 87. Pfizer Revenue in Female Health Business (2019-2024) & (US$ Million)
    Table 88. Pfizer Recent Developments
    Table 89. Teva Pharmaceuticals Company Details
    Table 90. Teva Pharmaceuticals Business Overview
    Table 91. Teva Pharmaceuticals Female Health Product
    Table 92. Teva Pharmaceuticals Revenue in Female Health Business (2019-2024) & (US$ Million)
    Table 93. Teva Pharmaceuticals Recent Developments
    Table 94. Agile Therapeutics Company Details
    Table 95. Agile Therapeutics Business Overview
    Table 96. Agile Therapeutics Female Health Product
    Table 97. Agile Therapeutics Revenue in Female Health Business (2019-2024) & (US$ Million)
    Table 98. Agile Therapeutics Recent Developments
    Table 99. Amgen, Inc. Company Details
    Table 100. Amgen, Inc. Business Overview
    Table 101. Amgen, Inc. Female Health Product
    Table 102. Amgen, Inc. Revenue in Female Health Business (2019-2024) & (US$ Million)
    Table 103. Amgen, Inc. Recent Developments
    Table 104. AstraZeneca Company Details
    Table 105. AstraZeneca Business Overview
    Table 106. AstraZeneca Female Health Product
    Table 107. AstraZeneca Revenue in Female Health Business (2019-2024) & (US$ Million)
    Table 108. AstraZeneca Recent Developments
    Table 109. Bristol-Myers Squibb Company Details
    Table 110. Bristol-Myers Squibb Business Overview
    Table 111. Bristol-Myers Squibb Female Health Product
    Table 112. Bristol-Myers Squibb Revenue in Female Health Business (2019-2024) & (US$ Million)
    Table 113. Bristol-Myers Squibb Recent Developments
    Table 114. Research Programs/Design for This Report
    Table 115. Key Data Information from Secondary Sources
    Table 116. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Female Health Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Female Health Market Share by Type: 2023 VS 2030
    Figure 3. Medicines Features
    Figure 4. Treatment Features
    Figure 5. Other Features
    Figure 6. Global Female Health Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Female Health Market Share by Application: 2023 VS 2030
    Figure 8. Postmenopausal Osteoporosis Case Studies
    Figure 9. Infertility Case Studies
    Figure 10. Endometriosis Case Studies
    Figure 11. PCOS Case Studies
    Figure 12. Other Case Studies
    Figure 13. Female Health Report Years Considered
    Figure 14. Global Female Health Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Female Health Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Female Health Market Share by Region: 2023 VS 2030
    Figure 17. Global Female Health Market Share by Players in 2023
    Figure 18. Global Top Female Health Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Female Health as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Female Health Revenue in 2023
    Figure 20. North America Female Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Female Health Market Share by Type (2019-2030)
    Figure 22. North America Female Health Market Share by Application (2019-2030)
    Figure 23. North America Female Health Market Share by Country (2019-2030)
    Figure 24. United States Female Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada Female Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Female Health Market Size YoY (2019-2030) & (US$ Million)
    Figure 27. Europe Female Health Market Share by Type (2019-2030)
    Figure 28. Europe Female Health Market Share by Application (2019-2030)
    Figure 29. Europe Female Health Market Share by Country (2019-2030)
    Figure 30. Germany Female Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. France Female Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. U.K. Female Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Italy Female Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Russia Female Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Nordic Countries Female Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. China Female Health Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. China Female Health Market Share by Type (2019-2030)
    Figure 38. China Female Health Market Share by Application (2019-2030)
    Figure 39. Asia Female Health Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. Asia Female Health Market Share by Type (2019-2030)
    Figure 41. Asia Female Health Market Share by Application (2019-2030)
    Figure 42. Asia Female Health Market Share by Region (2019-2030)
    Figure 43. Japan Female Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. South Korea Female Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. China Taiwan Female Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Female Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. India Female Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Australia Female Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Female Health Market Size YoY (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Female Health Market Share by Type (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Female Health Market Share by Application (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Female Health Market Share by Country (2019-2030)
    Figure 53. Brazil Female Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Mexico Female Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Turkey Female Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Saudi Arabia Female Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Israel Female Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. GCC Countries Female Health Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Veru Inc. Revenue Growth Rate in Female Health Business (2019-2024)
    Figure 60. Allergan Revenue Growth Rate in Female Health Business (2019-2024)
    Figure 61. Bayer AG Revenue Growth Rate in Female Health Business (2019-2024)
    Figure 62. Merck Revenue Growth Rate in Female Health Business (2019-2024)
    Figure 63. Pfizer Revenue Growth Rate in Female Health Business (2019-2024)
    Figure 64. Teva Pharmaceuticals Revenue Growth Rate in Female Health Business (2019-2024)
    Figure 65. Agile Therapeutics Revenue Growth Rate in Female Health Business (2019-2024)
    Figure 66. Amgen, Inc. Revenue Growth Rate in Female Health Business (2019-2024)
    Figure 67. AstraZeneca Revenue Growth Rate in Female Health Business (2019-2024)
    Figure 68. Bristol-Myers Squibb Revenue Growth Rate in Female Health Business (2019-2024)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed